SUMMARY In a group of six Parkinsonian patients and 13 "controls" with non-Parkinsonian neurological disease, there was a high correlation between both free and conjugated phenylacetic acid concentrations in plasma and cerebrospinal fluid taken at about the same time. This compound is the major metabolite of phenylethylamine, the production of which may be disturbed in a number of neuropsychiatric illnesses. Thus plasma measurements might be employed clinically to provide an estimate of central changes in phenylethylamine economy. A small but significantly higher proportion of conjugated phenylacetic acid was present in the plasma (but not cerebrospinal fluid) of Parkinsonians compared with controls.
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Phenylacetic acid is the major metabolite of phenylethylamine, a "trace amine"'l which has become the focus of considerable clinical attention in recent years. This amine has been invoked as a possible aetiological agent in the pathogenesis of certain disease states, including depressive illness,2 schizophrenia,3 migraine4 and aggressive psychopathy.5 Because phenylethylamine itself is normally present in body fluids in very low concentration requiring extremely sensitive methods for its estimation which, by their nature, are exacting and prone to interference, phenylacetic acid assay has become accepted as a guide to the production of its parent monoamine. Like phenylethylamine, unconjugated phenylacetic acid is a lipid-soluble relatively non-polar compound which might be expected to penetrate cell-membrane barriers with some facility. However, in the cat at least, the 14C-labelled acid is only able to cross the blood-brain barrier with difficulty. Mean (± SD) concentrations of free, conjugated and total phenylacetic acid in Parkinsonian and control plasma and CSF are shown in table 1. In both groups there were highly significant correlations between plasma and CSF concentrations of free, conjugated and total phenylacetic acid respectively. There was a small but significantly higher proportion of plasma (but not CSF) conjugated phenylacetic acid in Parkinsonians compared with controls (table 2).
Discussion
Although plasma concentrations of free acid were at 367 least five times higher than those of CSF and the plasma levels of conjugated phenylacetic acid exceeded those of CSF at least twelve-fold, CSF values in an individual changed sensitively in direct proportion to those of the corresponding plasma. It may thus be inferred that, had Sandier et al measured plasma phenylacetic acid concentrations in their depressive8 or schizophrenic9 series, they would respectively have been decreased or increased, in proportion to the CSF values obtained. Had it, conversely, been practicable to acquire CSF samples from the aggressive psychopaths5 they described, we may suppose that they would have followed the raised plasma values observed in these subjects.
Despite the general consensus that phenylacetic acid production mirrors that of endogenous phenylethylamine, findings have begun to emerge making a reassessment of this view timely: germ-free rats excrete only about one quarter as much total phenylacetic acid as conventional controls,1' suggesting a sizeable contribution from the gut flora. However, the proportion of phenylacetic acid provided by gut flora (if these data can be extrapolated to man) may derive from some route of degradation different from that initiated by phenylalanine decarboxylation to phenylethylamine. Although the output of the latter is increased substantially in man following complete and irreversible inhibition of the phenylethylamine-preferring monoamine oxidase B by deprenyl,'2 the total is still only a 
